4//SEC Filing
OCULAR THERAPEUTIX, INC 4
Accession 0001209191-14-049769
$OCULCIK 0001393434operating
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 5:32 PM ET
Size
12.3 KB
Accession
0001209191-14-049769
Insider Transaction Report
Form 4
Chadha Jaswinder
Director
Transactions
- Conversion
Common Stock
2014-07-30+92,570→ 130,448 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2014-07-30−100,000→ 0 total(indirect: See Footnote)→ Common Stock (37,878 underlying) - Conversion
Series B Preferred Stock
2014-07-30−27,144→ 0 total(indirect: See Footnote)→ Common Stock (10,282 underlying) - Conversion
Series C Preferred Stock
2014-07-30−117,243→ 0 total(indirect: See Footnote)→ Common Stock (44,410 underlying)
Footnotes (2)
- [F1]Each share of Series A, Series B and Series C Preferred Stock converted into Common Stock on a 2.64-for-one basis upon the closing of the Issuer's initial public offering of common stock for no additional consideration. The preferred stock had no expiration date.
- [F2]The securities are directly held by the Jaswinder Chadha 2007 Delaware Trust. The Reporting Person is the beneficiary of the Jaswinder Chadha 2007 Delaware Trust.
Documents
Issuer
OCULAR THERAPEUTIX, INC
CIK 0001393434
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001393434
Filing Metadata
- Form type
- 4
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 5:32 PM ET
- Size
- 12.3 KB